Nonopioid perioperative analgesia in head and neck cancer surgery: A systematic review

Abstract Objective Management of postoperative pain after head and neck cancer surgery is a complex issue, requiring a careful balance of analgesic properties and side effects. The objective of this review is to discuss the efficacy and safety of multimodal analgesia (MMA) for these patients. Method...

Full description

Bibliographic Details
Main Authors: Beatrice C. Go, Cammille C. Go, Kevin Chorath, Alvaro Moreira, Karthik Rajasekaran
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:World Journal of Otorhinolaryngology-Head and Neck Surgery
Subjects:
Online Access:https://doi.org/10.1002/wjo2.62
_version_ 1797733442934276096
author Beatrice C. Go
Cammille C. Go
Kevin Chorath
Alvaro Moreira
Karthik Rajasekaran
author_facet Beatrice C. Go
Cammille C. Go
Kevin Chorath
Alvaro Moreira
Karthik Rajasekaran
author_sort Beatrice C. Go
collection DOAJ
description Abstract Objective Management of postoperative pain after head and neck cancer surgery is a complex issue, requiring a careful balance of analgesic properties and side effects. The objective of this review is to discuss the efficacy and safety of multimodal analgesia (MMA) for these patients. Methods Pubmed, Cochrane, Embase, Scopus, and clinicaltrials.gov were systematically searched for all comparative studies of patients receiving MMA (nonsteroidal anti‐inflammatory drugs (NSAIDs), acetaminophen, anticonvulsants, local anesthetics, and corticosteroids) for head and neck cancer surgeries. The primary outcome was additional postoperative opioid usage, and secondary outcomes included subjective pain scores, complications, adverse effects, and 30‐day outcomes. Results A total of five studies representing 592 patients (MMA, n = 275; non‐MMA, n = 317) met inclusion criteria. The most commonly used agents were gabapentin, NSAIDs, and acetaminophen (n = 221), NSAIDs (n = 221), followed by corticosteroids (n = 35), dextromethorphan (n = 40), and local nerve block (n = 19). Four studies described a significant decrease in overall postoperative narcotic usage with two studies reporting a significant decrease in hospital time. Subjective pain scores widely varied with two studies reporting reduced pain at postoperative day 3. There were no differences in surgical outcomes, medical complications, adverse effects, or 30‐day mortality and readmission rates. Conclusion MMA is an increasingly popular strategy that may reduce dependence on opioids for the treatment of postoperative pain. A variety of regimens and protocols are available for providers to utilize in the appropriate head and neck cancer patient.
first_indexed 2024-03-12T12:29:12Z
format Article
id doaj.art-ecc3c8e7b328422ebb2a4e7868b2e396
institution Directory Open Access Journal
issn 2095-8811
2589-1081
language English
last_indexed 2024-03-12T12:29:12Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series World Journal of Otorhinolaryngology-Head and Neck Surgery
spelling doaj.art-ecc3c8e7b328422ebb2a4e7868b2e3962023-08-29T18:05:48ZengWileyWorld Journal of Otorhinolaryngology-Head and Neck Surgery2095-88112589-10812022-06-018210711710.1002/wjo2.62Nonopioid perioperative analgesia in head and neck cancer surgery: A systematic reviewBeatrice C. Go0Cammille C. Go1Kevin Chorath2Alvaro Moreira3Karthik Rajasekaran4Department of Otorhinolaryngology University of Pennsylvania Philadelphia Pennsylvania USAPerelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USADepartment of Otorhinolaryngology University of Pennsylvania Philadelphia Pennsylvania USADepartment of Pediatrics, Division of Neonatology University of Texas Health‐San Antonio San Antonio Texas USADepartment of Otorhinolaryngology University of Pennsylvania Philadelphia Pennsylvania USAAbstract Objective Management of postoperative pain after head and neck cancer surgery is a complex issue, requiring a careful balance of analgesic properties and side effects. The objective of this review is to discuss the efficacy and safety of multimodal analgesia (MMA) for these patients. Methods Pubmed, Cochrane, Embase, Scopus, and clinicaltrials.gov were systematically searched for all comparative studies of patients receiving MMA (nonsteroidal anti‐inflammatory drugs (NSAIDs), acetaminophen, anticonvulsants, local anesthetics, and corticosteroids) for head and neck cancer surgeries. The primary outcome was additional postoperative opioid usage, and secondary outcomes included subjective pain scores, complications, adverse effects, and 30‐day outcomes. Results A total of five studies representing 592 patients (MMA, n = 275; non‐MMA, n = 317) met inclusion criteria. The most commonly used agents were gabapentin, NSAIDs, and acetaminophen (n = 221), NSAIDs (n = 221), followed by corticosteroids (n = 35), dextromethorphan (n = 40), and local nerve block (n = 19). Four studies described a significant decrease in overall postoperative narcotic usage with two studies reporting a significant decrease in hospital time. Subjective pain scores widely varied with two studies reporting reduced pain at postoperative day 3. There were no differences in surgical outcomes, medical complications, adverse effects, or 30‐day mortality and readmission rates. Conclusion MMA is an increasingly popular strategy that may reduce dependence on opioids for the treatment of postoperative pain. A variety of regimens and protocols are available for providers to utilize in the appropriate head and neck cancer patient.https://doi.org/10.1002/wjo2.62analgesiahead and neck neoplasmNSAIDopioidspain management
spellingShingle Beatrice C. Go
Cammille C. Go
Kevin Chorath
Alvaro Moreira
Karthik Rajasekaran
Nonopioid perioperative analgesia in head and neck cancer surgery: A systematic review
World Journal of Otorhinolaryngology-Head and Neck Surgery
analgesia
head and neck neoplasm
NSAID
opioids
pain management
title Nonopioid perioperative analgesia in head and neck cancer surgery: A systematic review
title_full Nonopioid perioperative analgesia in head and neck cancer surgery: A systematic review
title_fullStr Nonopioid perioperative analgesia in head and neck cancer surgery: A systematic review
title_full_unstemmed Nonopioid perioperative analgesia in head and neck cancer surgery: A systematic review
title_short Nonopioid perioperative analgesia in head and neck cancer surgery: A systematic review
title_sort nonopioid perioperative analgesia in head and neck cancer surgery a systematic review
topic analgesia
head and neck neoplasm
NSAID
opioids
pain management
url https://doi.org/10.1002/wjo2.62
work_keys_str_mv AT beatricecgo nonopioidperioperativeanalgesiainheadandneckcancersurgeryasystematicreview
AT cammillecgo nonopioidperioperativeanalgesiainheadandneckcancersurgeryasystematicreview
AT kevinchorath nonopioidperioperativeanalgesiainheadandneckcancersurgeryasystematicreview
AT alvaromoreira nonopioidperioperativeanalgesiainheadandneckcancersurgeryasystematicreview
AT karthikrajasekaran nonopioidperioperativeanalgesiainheadandneckcancersurgeryasystematicreview